Visual impairment burden in retinopathy of prematurity: trends, inequalities, and improvement gaps-Reference-Cited by-同舟云学术

Visual impairment burden in retinopathy of prematurity: trends, inequalities, and improvement gaps

Published:2024-02-06 Issue: Volume: Page:
ISSN:1432-1076
Container-title:European Journal of Pediatrics
language:en
Short-container-title:Eur J Pediatr

Author:

Chen Jianqi,Zhu Yingting,Li Linling,Lv Juan,Li Zhidong,Chen Xuhao,Chen Xiaohong,Huang Shaofen,Xie Rui,Zhang Yuan,Ye Guitong,Luo Ruiyu,Shen Xinyue,Fu Min,Zhuo Yehong

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Science and Technology Program of Guangzhou, China

Major Science and Technology Project of Zhongshan City

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00431-024-05450-5.pdf

Reference23 articles.

1. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B; Cryotherapy For Retinopathy of Prematurity Cooperative Group (2020) Incidence and early course of retinopathy of prematurity. Ophthalmology 127:S84–S96. https://doi.org/10.1016/j.ophtha.2020.01.034

2. Gilbert C (2008) Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 84:77–82. https://doi.org/10.1016/j.earlhumdev.2007.11.009

3. Marlow N, Stahl A, Lepore D, Fielder A, Reynolds JD, Zhu Q, Weisberger A, Stiehl DP, Fleck B, RAINBOW investigators group, (2021) 2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial. Lancet Child Adolesc Health 5(10):698–707. https://doi.org/10.1016/S2352-4642(21)00195-4

4. Msall ME, Phelps DL, DiGaudio KM, Dobson V, Tung B, McClead RE, Quinn GE, Reynolds JD, Hardy RJ, Palmer EA (2000) Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the cryotherapy for retinopathy of prematurity Cooperative Group. Pediatrics 106:998–1005. https://doi.org/10.1542/peds.106.5.998

5. Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF, Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators, (2003) Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 289:1124–1129. https://doi.org/10.1001/jama.289.9.1124